Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Metformin decreases bone turnover markers in polycystic ovary syndrome: a post hoc study.

Lingaiah S, Morin-Papunen L, Risteli J, Tapanainen JS.

Fertil Steril. 2019 Jun 18. pii: S0015-0282(19)30388-7. doi: 10.1016/j.fertnstert.2019.04.013. [Epub ahead of print]

PMID:
31227287
2.

Serum retinol-binding protein 4 levels in polycystic ovary syndrome.

Lingaiah S, Morin-Papunen L, Piltonen T, Sundström-Poromaa I, Stener-Victorin E, Tapanainen JS.

Endocr Connect. 2019 Jun 1;8(6):709-717. doi: 10.1530/EC-19-0116.

3.

Hormone profiling, including anti-Müllerian hormone (AMH), for the diagnosis of polycystic ovary syndrome (PCOS) and characterization of PCOS phenotypes.

Sova H, Unkila-Kallio L, Tiitinen A, Hippeläinen M, Perheentupa A, Tinkanen H, Puukka K, Bloigu R, Piltonen T, Tapanainen JS, Morin-Papunen L.

Gynecol Endocrinol. 2019 Jul;35(7):595-600. doi: 10.1080/09513590.2018.1559807. Epub 2019 Jan 22.

PMID:
30668196
4.

Circulating antimüllerian hormone and steroid hormone levels remain high in pregnant women with polycystic ovary syndrome at term.

Piltonen TT, Giacobini P, Edvinsson Å, Hustad S, Lager S, Morin-Papunen L, Tapanainen JS, Sundström-Poromaa I, Arffman RK.

Fertil Steril. 2019 Mar;111(3):588-596.e1. doi: 10.1016/j.fertnstert.2018.11.028. Epub 2019 Jan 7.

5.

Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria.

Day F, Karaderi T, Jones MR, Meun C, He C, Drong A, Kraft P, Lin N, Huang H, Broer L, Magi R, Saxena R, Laisk T, Urbanek M, Hayes MG, Thorleifsson G, Fernandez-Tajes J, Mahajan A, Mullin BH, Stuckey BGA, Spector TD, Wilson SG, Goodarzi MO, Davis L, Obermayer-Pietsch B, Uitterlinden AG, Anttila V, Neale BM, Jarvelin MR, Fauser B, Kowalska I, Visser JA, Andersen M, Ong K, Stener-Victorin E, Ehrmann D, Legro RS, Salumets A, McCarthy MI, Morin-Papunen L, Thorsteinsdottir U, Stefansson K; 23andMe Research Team, Styrkarsdottir U, Perry JRB, Dunaif A, Laven J, Franks S, Lindgren CM, Welt CK.

PLoS Genet. 2018 Dec 19;14(12):e1007813. doi: 10.1371/journal.pgen.1007813. eCollection 2018 Dec.

6.

Self-Reported Polycystic Ovary Syndrome Is Associated With Hypertension: A Northern Finland Birth Cohort 1966 Study.

Ollila ME, Kaikkonen K, Järvelin MR, Huikuri HV, Tapanainen JS, Franks S, Piltonen TT, Morin-Papunen L.

J Clin Endocrinol Metab. 2019 Apr 1;104(4):1221-1231. doi: 10.1210/jc.2018-00570.

PMID:
30445634
7.

Polycystic ovary syndrome and risk factors for gestational diabetes.

Mustaniemi S, Vääräsmäki M, Eriksson JG, Gissler M, Laivuori H, Ijäs H, Bloigu A, Kajantie E, Morin-Papunen L.

Endocr Connect. 2018 Jul;7(7):859-869. doi: 10.1530/EC-18-0076. Epub 2018 Jun 1.

8.

The Long-Term Footprint of Endometriosis: Population-Based Cohort Analysis Reveals Increased Pain Symptoms and Decreased Pain Tolerance at Age 46 Years.

Vuontisjärvi S, Rossi HR, Herrala S, Morin-Papunen L, Tapanainen JS, Karjula S, Karppinen J, Auvinen J, Piltonen TT.

J Pain. 2018 Jul;19(7):754-763. doi: 10.1016/j.jpain.2018.02.005. Epub 2018 Mar 2.

PMID:
29496639
9.

The prevalence of Type 2 diabetes is not increased in normal-weight women with PCOS.

Pelanis R, Mellembakken JR, Sundström-Poromaa I, Ravn P, Morin-Papunen L, Tapanainen JS, Piltonen T, Puurunen J, Hirschberg AL, Fedorcsak P, Andersen M, Glintborg D.

Hum Reprod. 2017 Nov 1;32(11):2279-2286. doi: 10.1093/humrep/dex294.

PMID:
29040530
10.

Bone markers in polycystic ovary syndrome: A multicentre study.

Lingaiah S, Morin-Papunen L, Piltonen T, Puurunen J, Sundström-Poromaa I, Stener-Victorin E, Bloigu R, Risteli J, Tapanainen JS.

Clin Endocrinol (Oxf). 2017 Dec;87(6):673-679. doi: 10.1111/cen.13456. Epub 2017 Sep 21.

PMID:
28845895
11.

Testosterone is associated with insulin resistance index independently of adiposity in women with polycystic ovary syndrome.

Luotola K, Piltonen TT, Puurunen J, Morin-Papunen LC, Tapanainen JS.

Gynecol Endocrinol. 2018 Jan;34(1):40-44. doi: 10.1080/09513590.2017.1342793. Epub 2017 Jul 5.

PMID:
28678568
12.

Racial and ethnic differences in the prevalence of metabolic syndrome and its components of metabolic syndrome in women with polycystic ovary syndrome: a regional cross-sectional study.

Chan JL, Kar S, Vanky E, Morin-Papunen L, Piltonen T, Puurunen J, Tapanainen JS, Maciel GAR, Hayashida SAY, Soares JM Jr, Baracat EC, Mellembakken JR, Dokras A.

Am J Obstet Gynecol. 2017 Aug;217(2):189.e1-189.e8. doi: 10.1016/j.ajog.2017.04.007. Epub 2017 Apr 8.

PMID:
28400308
13.

Psychological Distress Is More Prevalent in Fertile Age and Premenopausal Women With PCOS Symptoms: 15-Year Follow-Up.

Karjula S, Morin-Papunen L, Auvinen J, Ruokonen A, Puukka K, Franks S, Järvelin MR, Tapanainen JS, Jokelainen J, Miettunen J, Piltonen TT.

J Clin Endocrinol Metab. 2017 Jun 1;102(6):1861-1869. doi: 10.1210/jc.2016-3863.

14.

Should we individualize lipid profiling in women with polycystic ovary syndrome?

Poromaa IS, Mellembakken JR, Morin-Papunen L, Piltonen T, Puurenen J, Tapanainen JS, Stener-Victorin E, Hirschberg AL, Vanky E, Ravn P, Glintborg D, Andersen M.

Hum Reprod. 2017 Apr 1;32(4):966. doi: 10.1093/humrep/dex009. No abstract available.

PMID:
28175322
15.

Normo- and hyperandrogenic women with polycystic ovary syndrome exhibit an adverse metabolic profile through life.

Pinola P, Puukka K, Piltonen TT, Puurunen J, Vanky E, Sundström-Poromaa I, Stener-Victorin E, Lindén Hirschberg A, Ravn P, Skovsager Andersen M, Glintborg D, Mellembakken JR, Ruokonen A, Tapanainen JS, Morin-Papunen LC.

Fertil Steril. 2017 Mar;107(3):788-795.e2. doi: 10.1016/j.fertnstert.2016.12.017. Epub 2017 Jan 12.

PMID:
28089571
16.

Should we individualize lipid profiling in women with polycystic ovary syndrome?

Sundström Poromaa I, Mellembakken JR, Morin-Papunen L, Piltonen T, Puurunen J, Tapanainen JS, Stener-Victorin E, Hirschberg AL, Vanky E, Ravn P, Glintborg D, Andersen M.

Hum Reprod. 2016 Dec;31(12):2791-2795. Epub 2016 Sep 22. Erratum in: Hum Reprod. 2017 Apr 1;32(4):966.

PMID:
27664213
17.

Effects of hormonal contraception on systemic metabolism: cross-sectional and longitudinal evidence.

Wang Q, Würtz P, Auro K, Morin-Papunen L, Kangas AJ, Soininen P, Tiainen M, Tynkkynen T, Joensuu A, Havulinna AS, Aalto K, Salmi M, Blankenberg S, Zeller T, Viikari J, Kähönen M, Lehtimäki T, Salomaa V, Jalkanen S, Järvelin MR, Perola M, Raitakari OT, Lawlor DA, Kettunen J, Ala-Korpela M.

Int J Epidemiol. 2016 Oct;45(5):1445-1457. Epub 2016 Aug 18.

18.

Ovarian tissue cryopreservation and transplantation among alternatives for fertility preservation in the Nordic countries - compilation of 20 years of multicenter experience.

Rodriguez-Wallberg KA, Tanbo T, Tinkanen H, Thurin-Kjellberg A, Nedstrand E, Kitlinski ML, Macklon KT, Ernst E, Fedder J, Tiitinen A, Morin-Papunen L, Einarsson S, Jokimaa V, Hippeläinen M, Lood M, Gudmundsson J, Olofsson JI, Andersen CY.

Acta Obstet Gynecol Scand. 2016 Sep;95(9):1015-26. doi: 10.1111/aogs.12934. Epub 2016 Jul 3.

19.

Weight Gain and Dyslipidemia in Early Adulthood Associate With Polycystic Ovary Syndrome: Prospective Cohort Study.

Ollila MM, Piltonen T, Puukka K, Ruokonen A, Järvelin MR, Tapanainen JS, Franks S, Morin-Papunen L.

J Clin Endocrinol Metab. 2016 Feb;101(2):739-47. doi: 10.1210/jc.2015-3543. Epub 2015 Dec 10.

20.

[Current Care Guideline: Eating disorders].

Suokas J, Alenius H, Ebeling H, Haapasalo-Pesu KM, Järvi L, Koskinen M, Laukkanen E, Meskanen K, Morin-Papunen L, Ryöppönen A, Salonen U, Tossavainen P, Vuorela P; Päivitystiivistelmä.

Duodecim. 2015;131(12):1200-1. Finnish.

PMID:
26245050
21.

Androgen Profile Through Life in Women With Polycystic Ovary Syndrome: A Nordic Multicenter Collaboration Study.

Pinola P, Piltonen TT, Puurunen J, Vanky E, Sundström-Poromaa I, Stener-Victorin E, Ruokonen A, Puukka K, Tapanainen JS, Morin-Papunen LC.

J Clin Endocrinol Metab. 2015 Sep;100(9):3400-7. doi: 10.1210/jc.2015-2123. Epub 2015 Jul 20.

PMID:
26192874
22.

The effect of atorvastatin treatment on serum oxysterol concentrations and cytochrome P450 3A4 activity.

Hukkanen J, Puurunen J, Hyötyläinen T, Savolainen MJ, Ruokonen A, Morin-Papunen L, Orešič M, Piltonen T, Tapanainen JS.

Br J Clin Pharmacol. 2015 Sep;80(3):473-9. doi: 10.1111/bcp.12701. Epub 2015 Jul 22.

23.

Statin therapy worsens insulin sensitivity in women with polycystic ovary syndrome (PCOS): a prospective, randomized, double-blind, placebo-controlled study.

Puurunen J, Piltonen T, Puukka K, Ruokonen A, Savolainen MJ, Bloigu R, Morin-Papunen L, Tapanainen JS.

J Clin Endocrinol Metab. 2013 Dec;98(12):4798-807. doi: 10.1210/jc.2013-2674. Epub 2013 Oct 23.

PMID:
24152688
24.

TBX6, LHX1 and copy number variations in the complex genetics of Müllerian aplasia.

Sandbacka M, Laivuori H, Freitas É, Halttunen M, Jokimaa V, Morin-Papunen L, Rosenberg C, Aittomäki K.

Orphanet J Rare Dis. 2013 Aug 16;8:125. doi: 10.1186/1750-1172-8-125.

25.

The Polycystic Ovary Syndrome and recent human evolution.

Corbett S, Morin-Papunen L.

Mol Cell Endocrinol. 2013 Jul 5;373(1-2):39-50. doi: 10.1016/j.mce.2013.01.001. Epub 2013 Jan 23. Review.

PMID:
23352610
26.

Metformin decreases serum 8-hydroxy-2'-deoxyguanosine levels in polycystic ovary syndrome.

Sova H, Puistola U, Morin-Papunen L, Karihtala P.

Fertil Steril. 2013 Feb;99(2):593-8. doi: 10.1016/j.fertnstert.2012.10.013. Epub 2012 Oct 31.

PMID:
23122829
27.

[Treatment of infertility--part II (male infertility)].

Morin-Papunen L, Koivunen R.

Duodecim. 2012;128(15):1568-75. Review. Finnish.

PMID:
22970608
28.

[Treatment of infertility].

Morin-Papunen L, Koivunen R.

Duodecim. 2012;128(14):1478-85. Review. Finnish.

PMID:
22937607
29.

A genome-wide association meta-analysis of circulating sex hormone-binding globulin reveals multiple Loci implicated in sex steroid hormone regulation.

Coviello AD, Haring R, Wellons M, Vaidya D, Lehtimäki T, Keildson S, Lunetta KL, He C, Fornage M, Lagou V, Mangino M, Onland-Moret NC, Chen B, Eriksson J, Garcia M, Liu YM, Koster A, Lohman K, Lyytikäinen LP, Petersen AK, Prescott J, Stolk L, Vandenput L, Wood AR, Zhuang WV, Ruokonen A, Hartikainen AL, Pouta A, Bandinelli S, Biffar R, Brabant G, Cox DG, Chen Y, Cummings S, Ferrucci L, Gunter MJ, Hankinson SE, Martikainen H, Hofman A, Homuth G, Illig T, Jansson JO, Johnson AD, Karasik D, Karlsson M, Kettunen J, Kiel DP, Kraft P, Liu J, Ljunggren Ö, Lorentzon M, Maggio M, Markus MR, Mellström D, Miljkovic I, Mirel D, Nelson S, Morin Papunen L, Peeters PH, Prokopenko I, Raffel L, Reincke M, Reiner AP, Rexrode K, Rivadeneira F, Schwartz SM, Siscovick D, Soranzo N, Stöckl D, Tworoger S, Uitterlinden AG, van Gils CH, Vasan RS, Wichmann HE, Zhai G, Bhasin S, Bidlingmaier M, Chanock SJ, De Vivo I, Harris TB, Hunter DJ, Kähönen M, Liu S, Ouyang P, Spector TD, van der Schouw YT, Viikari J, Wallaschofski H, McCarthy MI, Frayling TM, Murray A, Franks S, Järvelin MR, de Jong FH, Raitakari O, Teumer A, Ohlsson C, Murabito JM, Perry JR.

PLoS Genet. 2012;8(7):e1002805. doi: 10.1371/journal.pgen.1002805. Epub 2012 Jul 19.

30.

Metformin improves pregnancy and live-birth rates in women with polycystic ovary syndrome (PCOS): a multicenter, double-blind, placebo-controlled randomized trial.

Morin-Papunen L, Rantala AS, Unkila-Kallio L, Tiitinen A, Hippeläinen M, Perheentupa A, Tinkanen H, Bloigu R, Puukka K, Ruokonen A, Tapanainen JS.

J Clin Endocrinol Metab. 2012 May;97(5):1492-500. doi: 10.1210/jc.2011-3061. Epub 2012 Mar 14.

PMID:
22419702
31.

Full-length visfatin levels are associated with inflammation in women with polycystic ovary syndrome.

Lajunen TK, Purhonen AK, Haapea M, Ruokonen A, Puukka K, Hartikainen AL, Savolainen MJ, Morin-Papunen L, Tapanainen JS, Franks S, Järvelin MR, Herzig KH.

Eur J Clin Invest. 2012 Mar;42(3):321-8. doi: 10.1111/j.1365-2362.2011.02586.x. Epub 2011 Sep 13.

PMID:
21913913
32.

Unfavorable hormonal, metabolic, and inflammatory alterations persist after menopause in women with PCOS.

Puurunen J, Piltonen T, Morin-Papunen L, Perheentupa A, Järvelä I, Ruokonen A, Tapanainen JS.

J Clin Endocrinol Metab. 2011 Jun;96(6):1827-34. doi: 10.1210/jc.2011-0039. Epub 2011 Mar 30.

PMID:
21450988
33.

Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia. HABENOX: a randomised multicentre trial.

Visser J, Ulander VM, Helmerhorst FM, Lampinen K, Morin-Papunen L, Bloemenkamp KW, Kaaja RJ.

Thromb Haemost. 2011 Feb;105(2):295-301. doi: 10.1160/TH10-05-0334. Epub 2010 Nov 23.

PMID:
21103659
34.

Metabolic and reproductive characteristics of first-degree relatives of women with self-reported oligo-amenorrhoea and hirsutism.

Torvinen A, Koivunen R, Pouta A, Franks S, Martikainen H, Bloigu A, Hartikainen AL, McCarthy MI, Ruokonen A, Järvelin MR, Morin-Papunen L.

Gynecol Endocrinol. 2011 Sep;27(9):630-5. doi: 10.3109/09513590.2010.520375. Epub 2010 Oct 5.

PMID:
20923278
35.

In combined first-trimester Down syndrome screening, the false-positive rate is not higher in pregnancies conceived after assisted reproduction compared with spontaneous pregnancies.

Matilainen M, Peuhkurinen S, Laitinen P, Jarvela I, Morin-Papunen L, Ryynanen M.

Fertil Steril. 2011 Jan;95(1):378-81. doi: 10.1016/j.fertnstert.2010.07.1048. Epub 2010 Aug 19.

PMID:
20723891
36.

Distinctively low levels of serum 8-hydroxydeoxyguanosine in women with polycystic ovary syndrome.

Sova H, Morin-Papunen L, Puistola U, Karihtala P.

Fertil Steril. 2010 Dec;94(7):2670-3. doi: 10.1016/j.fertnstert.2010.03.049. Epub 2010 Apr 28.

PMID:
20430377
37.

[Update on current care guidelines. Eating disorders in children and adolescents].

Ebeling H, Järvi L, Komulainen J, Koskinen M, Morin-Papunen L, Rissanen A, Tapanainen P; Suomalaisen Lääkäriseuran Duodecimin ja Suomen Lastenpsykiatriyhdistyksen Asettama Työryhmä.

Duodecim. 2009;125(22):2466-7. Finnish.

PMID:
20095117
38.

Chlamydia antibodies and self-reported symptoms of oligo-amenorrhea and hirsutism: a new etiologic factor in polycystic ovary syndrome?

Morin-Papunen LC, Duleba AJ, Bloigu A, Järvelin MR, Saikku P, Pouta A.

Fertil Steril. 2010 Oct;94(5):1799-804. doi: 10.1016/j.fertnstert.2009.10.021.

PMID:
19931073
39.

Adrenal androgen production capacity remains high up to menopause in women with polycystic ovary syndrome.

Puurunen J, Piltonen T, Jaakkola P, Ruokonen A, Morin-Papunen L, Tapanainen JS.

J Clin Endocrinol Metab. 2009 Jun;94(6):1973-8. doi: 10.1210/jc.2008-2583. Epub 2009 Mar 24.

PMID:
19318449
40.

Comparison of metabolic and inflammatory outcomes in women who used oral contraceptives and the levonorgestrel-releasing intrauterine device in a general population.

Morin-Papunen L, Martikainen H, McCarthy MI, Franks S, Sovio U, Hartikainen AL, Ruokonen A, Leinonen M, Laitinen J, Järvelin MR, Pouta A.

Am J Obstet Gynecol. 2008 Nov;199(5):529.e1-529.e10. doi: 10.1016/j.ajog.2008.04.013. Epub 2008 Jun 4.

PMID:
18533124
41.

Rosiglitazone treatment alleviates inflammation and improves liver function in overweight women with polycystic ovary syndrome: a randomized placebo-controlled study.

Rautio K, Tapanainen JS, Ruokonen A, Morin-Papunen LC.

Fertil Steril. 2007 Jan;87(1):202-6. Epub 2006 Oct 30.

PMID:
17074328
42.

[How obesity of girls during childhood and adolescent reflects to reproductive ability].

Morin-Papunen L, Tapanainen P.

Duodecim. 2005;121(17):1899-907. Review. Finnish. No abstract available.

PMID:
16262133
43.

Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.

Piltonen T, Morin-Papunen L, Koivunen R, Perheentupa A, Ruokonen A, Tapanainen JS.

Hum Reprod. 2005 Jul;20(7):1820-6. Epub 2005 Mar 31.

PMID:
15802325
44.

Ovarian age-related responsiveness to human chorionic gonadotropin in women with polycystic ovary syndrome.

Piltonen T, Koivunen R, Perheentupa A, Morin-Papunen L, Ruokonen A, Tapanainen JS.

J Clin Endocrinol Metab. 2004 Aug;89(8):3769-75.

PMID:
15292303
45.

A practice guideline for treatment of eating disorders in children and adolescents.

Ebeling H, Tapanainen P, Joutsenoja A, Koskinen M, Morin-Papunen L, Järvi L, Hassinen R, Keski-Rahkonen A, Rissanen A, Wahlbeck K; Finnish Medical Society Duodecim.

Ann Med. 2003;35(7):488-501. Review.

PMID:
14649331
46.

Metformin reduces serum C-reactive protein levels in women with polycystic ovary syndrome.

Morin-Papunen L, Rautio K, Ruokonen A, Hedberg P, Puukka M, Tapanainen JS.

J Clin Endocrinol Metab. 2003 Oct;88(10):4649-54.

PMID:
14557435
47.

Metformin versus ethinyl estradiol-cyproterone acetate in the treatment of nonobese women with polycystic ovary syndrome: a randomized study.

Morin-Papunen L, Vauhkonen I, Koivunen R, Ruokonen A, Martikainen H, Tapanainen JS.

J Clin Endocrinol Metab. 2003 Jan;88(1):148-56.

PMID:
12519844
48.

[Insulin resistance and infertility].

Koivunen R, Morin-Papunen L.

Duodecim. 2002;118(5):509-15. Review. Finnish. No abstract available.

PMID:
12232991

Supplemental Content

Loading ...
Support Center